Driving Biohealth Forward: BioForward Wisconsin Welcomes New Board Leaders to Propel Industry Growth

WISCONSIN / AGILITYPR.NEWS / December 18, 2024 / Madison, WI – BioForward Wisconsin, the leading advocate for Wisconsin's flourishing biohealth cluster, is proud to announce new Board of Directors appointments as it builds on a groundbreaking 2024. These achievements set the stage for even greater biohealth advancements and collaboration in 2025.

2024: A Year of Milestones

BioForward achieved transformative progress, including securing Phase II Tech Hub funding, releasing the 2024 WI Biohealth Economic Impact Report showcasing a $37.7 billion contribution to Wisconsin’s economy, and hosting a record-breaking Wisconsin Biohealth Summit. CEO Lisa Johnson stated, "These accomplishments are a testament to Wisconsin’s growing leadership in biohealth and relentless drive to innovate."

Welcoming New Board Members

BioForward proudly introduces three esteemed leaders to its Board of Directors:

• David Jeremy Katzmann, Ph.D., Senior Research Fellow, Biology, Arrowhead Pharmaceuticals
• Adam Lynch, Vice President, Finance & External Affairs, NorthStar Medical Radioisotopes
• Deena Ensenberger, Vice President, PPD, a part of Thermo Fisher Scientific

"This dynamic group of leaders brings unparalleled expertise to help shape the future of Wisconsin’s biohealth industry," said Nicolas Paris, CEO of Gilson and Board Chair. "Their contributions will be vital as we build on our 2024 successes."

Executive Committee

• Board Chair: Nicolas Paris, CEO, Gilson
• Board Treasurer: Garrett Peterson, Principal/Chief Strategy Officer, Yahara Software
• Board Secretary: Sarah Duellman, Global Strategic Business Lead, Biotech, Promega
• CEO: Lisa Johnson, BioForward Wisconsin

Continuing Board Members

• Anjon Audhya, Senior Associate Dean for Basic Research, Biotechnology, and Graduate Studies, University of Wisconsin School of Medicine and Public Health
• Jenny Fong, Site Head, Madison/Verona. Life Science Services/Synthesis & ADC CDMO, Millipore-Sigma
• Pam Gabris, Head, Alliance Management, Strategic Planning & Study Direction, Labcorp
• Justin Krause, Vice President, Operations, Coordination and Strategy, Exact Sciences
• Adam Kujath, Executive Vice President & Site Head, Sterling Pharma Solutions
• Edward Ladwig, GM & VP of Chemistry Operations, Eurofins
• Mara Lord, Sr. VP University Engagement & Strategic Planning, Medical College of Wisconsin
• Tom Lynch, Director, Technical Sales & Scientific Support, Aldevron
• Brad Pietz, Executive VP and Chief Laboratory Officer, Versiti
• Eric Ruedinger, VP & GM, Pharmaceutical Diagnostics, GE HealthCare
• Angela Ryan, VP Clinical IVD Product Management, Illumina
• Zachary Taylor, Senior Director of Operations, Catalent Pharma Solutions

Driving Forward in 2025

"With a strengthened board and unified vision, BioForward is poised to elevate Wisconsin’s biohealth innovation on a global scale," Johnson emphasized. "Our expanded leadership team will be instrumental in shaping the next chapter of impactful advancements."

For more information about the Board of Directors and BioForward Wisconsin’s initiatives, visit www.bioforward.org.